These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7789100)

  • 1. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
    Pfaller MA; Messer SA; Hollis RJ
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):9-14. PubMed ID: 7789100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis.
    Branchini ML; Pfaller MA; Rhine-Chalberg J; Frempong T; Isenberg HD
    J Clin Microbiol; 1994 Feb; 32(2):452-6. PubMed ID: 8150956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
    Zhang J; Hollis RJ; Pfaller MA
    Diagn Microbiol Infect Dis; 1997 Mar; 27(3):63-7. PubMed ID: 9147006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
    Berrouane YF; Hollis RJ; Pfaller MA
    J Clin Microbiol; 1996 Jul; 34(7):1856-8. PubMed ID: 8784612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
    Pfaller MA; Messer SA; Houston A; Rangel-Frausto MS; Wiblin T; Blumberg HM; Edwards JE; Jarvis W; Martin MA; Neu HC; Saiman L; Patterson JE; Dibb JC; Roldan CM; Rinaldi MG; Wenzel RP
    Diagn Microbiol Infect Dis; 1998 May; 31(1):289-96. PubMed ID: 9597389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.
    Pfaller MA; Messer SA; Hollis RJ
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):127-33. PubMed ID: 7874879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An outbreak of Candida parapsilosis prosthetic valve endocarditis.
    Diekema DJ; Messer SA; Hollis RJ; Wenzel RP; Pfaller MA
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):147-53. PubMed ID: 9401807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
    Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
    Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
    Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections.
    Barchiesi F; Di Francesco LF; Arzeni D; Caselli F; Simonetti O; Cellini A; Giacometti A; Offidani AM; Scalise G
    Mycopathologia; 2001; 149(3):117-21. PubMed ID: 11307593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of candidemia in a Turkish tertiary care hospital.
    Bakir M; Cerikcioglu N; Barton R; Yagci A
    APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
    St-Germain G; Laverdière M; Pelletier R; Bourgault AM; Libman M; Lemieux C; Noël G
    J Clin Microbiol; 2001 Mar; 39(3):949-53. PubMed ID: 11230409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.
    Barchiesi F; Falconi Di Francesco L; Arzeni D; Caselli F; Gallo D; Scalise G
    Eur J Clin Microbiol Infect Dis; 1999 Mar; 18(3):184-7. PubMed ID: 10357051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.